189 Gene expression changes in rat liver induced by two hypolipidemic drugs; A PPAR-α agonist and a HMG-CoA reductase inhibitor and diethylhexyl phthalate using affymetrix genechip® technology

Coa Reductase ◽

Hypolipidemic Drugs

Effect of NK-104, a new synthetic HMG-CoA reductase inhibitor, on triglyceride secretion and fatty acid oxidation in rat liver

Life Sciences ◽

10.1016/s0024-3205(99)00390-2 ◽

1999 ◽

Vol 65 (14) ◽

pp. 1493-1502 ◽

Cited By ~ 7

Author(s):

Kyosuke Yamamoto ◽

Naoki Todaka ◽

Hiromi Goto ◽

Anura P. Jayasooriya ◽

Masanobu Sakono ◽

...

Keyword(s):

Fatty Acid ◽

Fatty Acid Oxidation ◽

Rat Liver ◽

Reductase Inhibitor ◽

Acid Oxidation ◽

Hmg Coa Reductase ◽

Triglyceride Secretion ◽

In vitro inhibition of simvastatin metabolism, a HMG-CoA reductase inhibitor in human and rat liver by bergamottin, a component of grapefruit juice

European Journal of Pharmaceutical Sciences ◽

10.1016/s0928-0987(02)00222-1 ◽

2003 ◽

Vol 18 (1) ◽

pp. 31-35 ◽

Cited By ~ 18

Author(s):

Nathalie Le Goff-Klein ◽

Jean-Claude Koffel ◽

Louis Jung ◽

Geneviève Ubeaud

Keyword(s):

Rat Liver ◽

Reductase Inhibitor ◽

Grapefruit Juice ◽

Hmg Coa Reductase ◽

In Vitro Inhibition ◽

Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells

Oncology Reports ◽

10.3892/or.11.5.1053 ◽

2004 ◽

Author(s):

Takemi Otsuki ◽

Haruko Sakaguchi ◽

Tamayo Hatayama ◽

Tomohiro Fujii ◽

Takayuki Tsujioka ◽

...

Keyword(s):

Reductase Inhibitor ◽

Hmg Coa Reductase ◽

Myeloma Cells ◽

Coa Reductase ◽

Human Myeloma Cells

HMG-COA REDUCTASE INHIBITOR AFFECTS BLOOD PRESSURE AND VASCULAR REACTIVITY

Clinical and Experimental Pharmacology and Physiology ◽

10.1111/j.1440-1681.1995.tb02934.x ◽

1995 ◽

Vol 22 (s1) ◽

pp. S316-S317 ◽

Cited By ~ 1

Author(s):

N. Li ◽

M. Sawamura ◽

Y. Nara ◽

K. Kizawa ◽

K. Ikeda ◽

...

Keyword(s):

Blood Pressure ◽

Reductase Inhibitor ◽

Vascular Reactivity ◽

Hmg Coa Reductase ◽

Combined treatment of angiotensin receptor blocker and HMG-CoA reductase inhibitor synergistically improves cardiac dysfunction in Dahl rats

Journal of Molecular and Cellular Cardiology ◽

10.1016/j.yjmcc.2007.07.050 ◽

2008 ◽

Vol 44 (2) ◽

pp. 446-447

Author(s):

Yasuhiro Maejima ◽

Susumu Adachi ◽

Kazuya Isobe ◽

Hiroshi Ito ◽

Mitsuaki Isobe

Keyword(s):

Cardiac Dysfunction ◽

Reductase Inhibitor ◽

Angiotensin Receptor Blocker ◽

Combined Treatment ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Hmg Coa Reductase ◽

Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia

Atherosclerosis ◽

10.1016/s0021-9150(01)00765-1 ◽

2002 ◽

Vol 163 (1) ◽

pp. 157-164 ◽

Cited By ~ 59

Author(s):

Yoshihiro Noji ◽

Toshinori Higashikata ◽

Akihiro Inazu ◽

Atsushi Nohara ◽

Kosei Ueda ◽

...

Keyword(s):

Familial Hypercholesterolemia ◽

Reductase Inhibitor ◽

Term Treatment ◽

Hmg Coa Reductase ◽

Heterozygous Familial Hypercholesterolemia ◽

Long Term Treatment ◽

Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin

Cardiovascular Drugs and Therapy ◽

10.1007/bf01883868 ◽

1989 ◽

Vol 3 (2) ◽

pp. 219-227 ◽

Cited By ~ 3

Author(s):

GMB Berger ◽

AD Marais ◽

HC Seftel ◽

SG Baker ◽

D Mendelsohn ◽

...

Keyword(s):

Reductase Inhibitor ◽

Hmg Coa Reductase ◽

The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-β1–42 in the rat hippocampus in vivo

Neuropharmacology ◽

10.1016/j.neuropharm.2006.07.031 ◽

2007 ◽

Vol 52 (1) ◽

pp. 136-145 ◽

Cited By ~ 50

Author(s):

Rachael M. Clarke ◽

Florence O'Connell ◽

Anthony Lyons ◽

Marina A. Lynch

Keyword(s):

Reductase Inhibitor ◽

Rat Hippocampus ◽

Acute Administration ◽

Hmg Coa Reductase ◽

Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor

Klinische Wochenschrift ◽

10.1007/bf01745519 ◽

1988 ◽

Vol 66 (10) ◽

pp. 462-463 ◽

Cited By ~ 78

Author(s):

J. Thiery ◽

V. W. Armstrong ◽

J. Schleef ◽

C. Creutzfeldt ◽

W. Creutzfeldt ◽

...

Keyword(s):

Reductase Inhibitor ◽

Serum Lipoprotein ◽

Hmg Coa Reductase ◽

1P-0091 Long-term combination therapy with an HMG-COA reductase inhibitor, pravastatin, and an ACE inhibitor, captopril, seems to be beneficial for hypercholesterolemic hypertensives

Atherosclerosis Supplements ◽

10.1016/s1567-5688(03)90166-8 ◽

2003 ◽

Vol 4 (2) ◽

pp. 39

Author(s):

H. Shionoiri ◽

I. Takasaki ◽

F. Shionoiri

Keyword(s):

Combination Therapy ◽

Reductase Inhibitor ◽

Ace Inhibitor ◽

Hmg Coa Reductase ◽